Since early this year, the Obama administration has been shifting money around to cover the costs of the work being done by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the FDA and other federal agencies to address the Zika crisis in the Americas and to prepare the US for the invasion of the virus.
Robbing Ebola To Pay For Zika: Playing With Fire?
Since early this year, the Obama administration has been shifting money around to cover the costs of the work being done by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the FDA and other federal agencies to address the Zika crisis in the Americas and to prepare the US for the invasion of the virus.
More from Immunological
More from Therapy Areas
• By
Emma Walmsley tells Scrip that the "biotech market is under a certain degree of pressure," so reasonably priced deals are available.
• By
JAK inhibitor gains ninth indication in US after a strong performance in the first quarter.
• By
CSPC’s SYS6010, the first monospecific EGFR-targeting antibody-drug conjugate in the clinic for advanced NSCLC, has shown Phase I promise, but could face close competition with another China-originated bispecific.